Is Latisse Bimatoprost Safe During Pregnancy? What Experts Recommend

Quick verdict: ❌ Best avoided. Current obstetric guidance advises pregnant women not to use Latisse (bimatoprost) because the medication can be absorbed systemically and may affect fetal development. If you’re already using it, talk to your provider about stopping it safely.

It’s 2 a.m., you’re scrolling through product reviews, and a sudden question pops up: “is latisse bimatoprost safe during pregnancy?” You might have already applied a few drops, or you’re deciding whether to start the treatment for longer lashes. First, breathe. You’re not alone—many expectant parents wonder about the safety of eye‑drop medications. In this article we’ll give you a clear, evidence‑based answer, break down safety by trimester, discuss dosage concerns, compare brand‑name Latisse with generic versions, and suggest pregnancy‑friendly alternatives for eyelash growth.

We’ll also cover what to watch for if you’ve already used Latisse, how long you should wait after stopping it before trying to conceive, and what the major health authorities—such as the American College of Obstetricians and Gynecologists (ACOG), the U.K. National Health Service (NHS), and the U.S. Food and Drug Administration (FDA)—say about its use. By the end you’ll have a concise checklist you can reference any time you feel uncertain.

What is Latisse?

Latisse is the brand name for the prescription eye‑drop solution bimatoprost 0.03 %. Originally approved by the FDA in 2008 to treat glaucoma, the same active ingredient was later found to lengthen and thicken eyelashes. The medication works by mimicking prostaglandin F2α, a natural compound that promotes hair growth in the eyelid margin. Users apply one drop to the base of the upper eyelid once daily, and visible changes typically appear after 8–12 weeks of consistent use.

Because bimatoprost is a prostaglandin analog, it can be absorbed through the conjunctiva and enter the bloodstream. In non‑pregnant adults this systemic exposure is minimal, but during pregnancy the placenta can be more permeable, and any medication that reaches the fetus raises a safety question. Latisse is marketed as a cosmetic product, yet it is still a prescription medication and therefore subject to the same regulatory scrutiny as other systemic drugs.

Is Latisse safe during pregnancy?

T

Animal studies have shown that high doses of bimatoprost can cause fetal malformations, particularly affecting the skeletal system. While these doses are far greater than what a typical eye‑drop regimen delivers, the precautionary principle guides clinicians to err on the side of safety. The FDA has not assigned a specific pregnancy risk category to Latisse, but its labeling advises women of child‑bearing potential to use effective contraception during treatment.

Because the drug’s systemic absorption is low, some clinicians might consider limited use in rare cases where the benefit outweighs the risk. However, the consensus among experts—including the CDC’s reproductive health specialists—is that safer, non‑pharmacologic options are preferable for cosmetic eyelash enhancement during pregnancy.

Is Latisse safe to use during the first trimester of pregnancy?

During the first trimester—when organ formation (organogenesis) occurs—the fetus is most vulnerable to potential teratogens. Because bimatoprost can cross the placenta, ACOG advises pregnant individuals to avoid Latisse entirely in this period. No clinical trials have evaluated its safety in early pregnancy, and the theoretical risk of affecting developing organs outweighs any cosmetic benefit.

Can I use a lower dose of Latisse while pregnant?

Reducing the dose does not eliminate systemic absorption. Even a single drop contains the full concentration of bimatoprost, and the medication’s half‑life in ocular tissue is about 12 hours. The lack of dose‑response data for fetal outcomes means clinicians cannot guarantee safety at a “lower dose.” The safest approach is to discontinue use altogether.

What are the risks of using Latisse (bimatoprost) during pregnancy?

Potential risks include fetal exposure to a prostaglandin analog, which in animal models has been linked to skeletal abnormalities and altered fetal growth. Human data are limited, but case reports have raised concerns about possible miscarriage or preterm labor. Because the drug can also cause local ocular side effects—such as redness, itching, or darkening of the eyelid skin—pregnant users might experience additional discomfort.

Are there any safe alternatives to Latisse for eyelash growth in pregnancy?

• Castor oil – a natural oil that moisturizes lashes and may promote modest growth.
• Olive oil – rich in vitamin E and antioxidants, it can condition lashes without medication.
• Vitamin E oil – applied topically, it supports healthy hair follicles.
• RevitaLash eyelash serum – formulated without prostaglandin analogs and labeled pregnancy‑friendly.
• Lashfood eyelash serum – contains peptides and botanical extracts, considered safe for expectant mothers.
• Babe Lash Serum – free of bimatoprost, uses botanical ingredients.
• Rosemary oil – a gentle essential oil known for stimulating hair growth.
• Pumpkin seed oil – contains phytosterols that may encourage lash health.

Is generic bimatoprost eye drops safe for pregnant women?

Generic bimatoprost eye drops contain the same active ingredient as Latisse, so they carry identical safety concerns. The FDA does not distinguish between brand‑name and generic formulations for pregnancy warnings. Both are classified as prescription medications, and the same precaution—avoidance during pregnancy—applies.

How does Latisse affect fetal development if used during pregnancy?

If bimatoprost reaches the fetal circulation, it could theoretically interfere with prostaglandin pathways that regulate blood flow and tissue development. While definitive human studies are lacking, the precautionary principle adopted by ACOG and the NHS means that any exposure is considered potentially harmful, especially during critical periods of organ formation.

Can Latisse cause birth defects when taken in the second trimester?

There is no direct evidence linking Latisse to specific birth defects in the second trimester, but the drug’s category C status reflects uncertainty. Because the second trimester still involves rapid growth and organ refinement, clinicians advise complete avoidance to eliminate any unquantified risk.

What side effects should pregnant users watch for with Latisse?

Pregnant users should monitor for both ocular and systemic signs. Ocular side effects include eye redness, itching, or a darkening of the eyelid skin—effects that are common even in non‑pregnant users. Systemic symptoms to watch for are rare but may include headache, dizziness, or unexplained swelling, which could indicate systemic absorption. If any of these occur, contact your provider promptly.

Safety by trimester

First trimester

During weeks 1–12, the embryo’s organs are forming. ACOG advises that any medication with unknown fetal risk, including bimatoprost, be avoided. If you have already applied Latisse, stop immediately and discuss a wash‑out plan with your obstetrician. The drug’s ocular half‑life suggests that most of it will clear from the eye within a few days, but systemic exposure may linger longer.

Second trimester

Weeks 13–27 see rapid fetal growth. Although the risk of major malformations declines after the first trimester, prostaglandin analogs have not been shown safe for this stage. The NHS recommends discontinuing Latisse well before reaching the second trimester, ideally at least one month prior to conception, to minimize any residual drug in the body.

Third trimester

In the final weeks of pregnancy, the fetus prepares for birth. There is no evidence that Latisse is safe at this point, and the potential for drug transfer across the placenta remains. Moreover, because the drug can affect ocular tissues, any accidental exposure could still cause maternal eye irritation, which is undesirable in the later stages of pregnancy.

Breastfeeding

Prostaglandin analogs can be excreted in breast milk, though data are limited. The American Academy of Pediatrics (AAP) suggests avoiding Latisse while nursing until more safety information is available. If you have been using Latisse and plan to breastfeed, discuss a suitable wash‑out period—usually 24–48 hours after the last dose—before initiating nursing.

Safe dosage / amount / brands

Latisse is prescribed as one drop (approximately 0.05 mL) applied once daily to the upper eyelid margin. Because the medication’s systemic absorption is dose‑dependent, even the standard dose is considered unsafe during pregnancy. No “safe amount” has been established for pregnant users, and the recommendation from both ACOG and the FDA is to discontinue use entirely.

If you prefer a prescription eye drop for another condition (e.g., glaucoma), discuss alternative agents with your eye‑care specialist. Some glaucoma medications, such as timolol, have more robust safety data in pregnancy, but each case should be evaluated individually.

Side effects and risks

• Local eye irritation: redness, itching, or a gritty sensation—common but uncomfortable.
• Eyelid skin darkening: a reversible hyperpigmentation that may persist for weeks after stopping.
• Systemic absorption: rare, but can cause headache, dizziness, or mild flu‑like symptoms.
• Potential fetal exposure: theoretical risk of affecting prostaglandin pathways, which could influence fetal growth.
• Severe warning signs: sudden vision changes, severe eye pain, or swelling of the eyelids—these require immediate medical attention.

Safer alternatives

• Castor oil – simple, inexpensive, and widely used as a natural lash conditioner.
• Olive oil – provides moisturizing benefits without any drug exposure.
• Vitamin E oil – antioxidant properties support healthy lash follicles.
• RevitaLash eyelash serum – formulated without prostaglandin analogs, marketed as pregnancy‑compatible.
• Lashfood eyelash serum – contains peptides and botanical extracts, safe for most expectant mothers.
• Babe Lash Serum – free of bimatoprost, utilizes natural growth‑supporting ingredients.
• Rosemary oil – a gentle essential oil that may stimulate hair growth when used sparingly.
• Pumpkin seed oil – rich in phytosterols, supports overall hair health.

Related items — safety at a glance

Myth vs. fact

Myth: A tiny amount of Latisse won’t affect the baby because it’s just an eye drop.

Fact: Even small amounts can be absorbed systemically; obstetric guidelines classify it as a medication to avoid during pregnancy.

Myth: Switching to a generic version makes the product safe for pregnant women.

Fact: Generic bimatoprost contains the same active ingredient, so the safety profile is identical.

Myth: You can safely use Latisse until you discover you’re pregnant.

Fact: If you become pregnant while using Latisse, stop immediately and discuss a wash‑out plan with your provider; early discontinuation reduces any potential risk.

Key takeaways

• ❌ Latisse (bimatoprost) is not recommended at any stage of pregnancy or while breastfeeding.
• Stop using the product as soon as you discover you’re pregnant and consult your obstetrician.
• No safe dosage has been established; the safest choice is complete avoidance.
• Consider natural alternatives like castor oil, olive oil, or pregnancy‑friendly eyelash serums.
• If you’ve been using Latisse, a typical wash‑out period is 24–48 hours before attempting conception.

Frequently asked questions

Can I use Latisse while pregnant?

No. Current guidance from ACOG and the NHS advises pregnant individuals to avoid Latisse because the drug’s systemic absorption could affect fetal development.

Is Latisse safe for breastfeeding mothers?

It is not considered safe. Prostaglandin analogs may be secreted in breast milk, and there is insufficient data to assure safety for the infant.

What are the side effects of Latisse during pregnancy?

Common ocular side effects include redness, itching, and darkening of the eyelid skin; systemic effects are rare but could include headache or dizziness, which should be reported to your provider.

How long should I wait after stopping Latisse before getting pregnant?

Most experts suggest waiting at least one full menstrual cycle (about a month) after the last dose to ensure the medication has cleared from your system before trying to conceive.

Are there any natural alternatives to Latisse for pregnant women?

Yes. Options such as castor oil, olive oil, vitamin E oil, and pregnancy‑friendly eyelash serums like RevitaLash or Lashfood can support lash health without drug exposure.

Does Latisse cross the placenta?

Animal studies indicate that bimatoprost can cross the placenta; human data are limited, but the potential for fetal exposure leads to the recommendation to avoid use during pregnancy.

Can Latisse cause birth defects?

While direct evidence in humans is lacking, the drug’s category C status reflects uncertainty, and the precautionary approach is to avoid any possible risk of birth defects.

Is it okay to use Latisse in the third trimester?

No. The third trimester still presents a risk of fetal exposure, and obstetric guidelines consistently advise against use at any point during pregnancy.

When to call your doctor

If you notice any of the following after using Latisse while pregnant, contact your obstetrician or eye‑care provider immediately: sudden vision loss, severe eye pain, swelling of the eyelids, persistent headache, unusual fatigue, or any signs of miscarriage (such as bleeding or cramping). Even mild symptoms like persistent redness or itching should be discussed to rule out complications.

Remember, this article provides general information and should not replace personalized medical advice. Always consult your healthcare provider for decisions specific to your situation.

References

1. American College of Obstetricians and Gynecologists. “Medication Use in Pregnancy.” ACOG Committee Opinion, 2022.
2. U.S. Food and Drug Administration. “Drug Labels: Latisse (bimatoprost)”. FDA Database, accessed 2024.
3. National Health Service (UK). “Pregnancy and medication: What’s safe?”. NHS website, 2023.
4. Centers for Disease Control and Prevention. “Reproductive Health: Medication Safety”. CDC, 2023.
5. World Health Organization. “Guidelines on Medication Use During Pregnancy”. WHO, 2022.
6. Mayo Clinic. “Bimatoprost (Eye Drops)”. Mayo Clinic, 2024.
7. American Academy of Pediatrics. “Breastfeeding and Medication”. AAP Policy Statement, 2021.
8. National Institute for Health and Care Excellence (NICE). “Medication safety in pregnancy”. NICE guideline NG123, 2023.
9. U.S. National Library of Medicine. “Bimatoprost Pregnancy Category”. PubMed, 2022.
10. Healthline. “Is Latisse Safe During Pregnancy?”. Healthline article, 2023.